Search results
Results from the WOW.Com Content Network
Martin Shkreli (/ ˈ ʃ k r ɛ l i /; born March 17, 1983) is an American investor and businessman.Shkreli is the co-founder of the hedge funds Elea Capital, MSMB Capital Management, and MSMB Healthcare, the co-founder and former CEO of pharmaceutical firms Retrophin and Turing Pharmaceuticals, and the former CEO of start-up software company Gödel Systems, which he founded in August 2016.
NEW YORK, Aug 4 (Reuters) - Former drug company executive Martin Shkreli was convicted of securities fraud by jurors in a U.S. court in Brooklyn on Friday, after a highly publicized, monthlong trial.
Shkreli, 36, had been appealing his August 2017 conviction on two securities fraud counts and one conspiracy count. 'Pharma Bro' Martin Shkreli to stay behind bars, loses appeal of conviction Skip ...
Martin Shkreli: 87850-053: Released May 18, 2022 after serving four years, two months [13] Nicknamed the "pharma bro." Convicted of securities fraud. Was originally at Fort Dix, until it was discovered he was still running his company via a contraband cellphone, which led to his transfer to Allenwood. Tal Prihar: 12911-509
Martin Shkreli, the pharmaceutical entrepreneur serving a seven-year prison term for fraud, has settled all outstanding disputes with Retrophin Inc, the biopharmaceutical company he founded in ...
What links here; Related changes; Upload file; Special pages; Permanent link; Page information; Cite this page; Get shortened URL; Download QR code
Former Bloomberg reporter Christie Smythe was the talk of Twitter Sunday after a story about her decision to give up her husband and her job for convicted “Pharma Bro” Martin Shkreli went ...
NEW YORK (Reuters) -Martin Shkreli, known for once hiking the price of a life-saving drug more than 4,000%, cannot return to the pharmaceutical industry after a federal appeals court on Tuesday ...